30 results on '"Wittmann T"'
Search Results
2. Solid state and liquid ablation of polyethylene-glycol 1000: temperature dependence
3. P557 Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy
4. P545 Bolus administration of steroid therapy is more favourable than the conventional use in preventing decrease of bone density and the increase of body fat percentage in patients with inflammatory bowel disease
5. P344 Short and medium term efficacy of adalimumab in ulcerative colitis – a multicentre, prospective observational study
6. P321 The one-year efficacy of infliximab does not depend on the timing of biological therapy in ulcerative colitis
7. P158 Prospective comparison of magnetic resonance imaging, rectal and perineal ultrasound and the surgical findings of complicated perianal Crohn's disease: a new kid on the block
8. P119 The diagnostic value of a new fecal marker matrix metalloprotease-9 in different types of inflammatory bowel diseases
9. P112 The triggering role of Clostridium difficile infection in the relapse of IBD and the clinical utility of fecal calprotectin and matrix-metalloproteinase-9 in case of Clostridium-induced relapse
10. NHERF-1 regulates pancreatic ductal secretion and modulates the severity of experimental acute pancreatitis
11. P514 Efficacy of dose intensification of anti-TNF therapy in Crohn's disease – single center experience
12. P480 Importance of diet in inflammatory bowel disease – data from the patients’ view
13. P452 Long-term efficacy and safety of cyclosporine as a rescue therapy in acute, steroid-refractory severe ulcerative colitis
14. P449 Long-term increase of serum cholesterol level in ulcerative colitis patients treated with cyclosporine: an underdiagnosed side effect frequently associated with other drug-related complications
15. P402 Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
16. P274 Clinical utility of measuring serum TNF alpha level, anti TNF alpha levels and antibody titers in critical situations in inflammatory bowel disease and in psoriasis
17. P154 Risk factors for colectomy and pouchitis in ulcerative colitis patients with severe flare-up
18. P018 The role of human colonic ion transporters in diarrhea-associated diseases
19. The first hereditary pancreatitis family in Hungary
20. P436 Clinical course of ulcerative colitis according to the partial Mayo score based classification during two-year follow-up period: Result from a Hungarian multicenter IBD database
21. P382 Inflammatory bowel disease itself is a more important risk factor for impaired health-related quality of life than non-adherence to medical therapy
22. P378 High restarting rate among patients with Crohn's disease after cessation of one-year treatment period with biologicals: Result of national RASH study
23. P191 Risk factors for colectomy in ulcerative colitis patients with severe flare-up
24. P182 Fecal MMP-9: A new noninvasive differential diagnostic and activity marker in ulcerative colitis
25. P154 First diagnostic endoscopy does not predict disease course except stenosis, while smoking predisposes patients to severe endoscopic relapse in Crohn's disease
26. P166 - Long term colectomy rate in steroid responder and steroid-dependent, cyclosporine treated patients
27. P071 - Mythbusters: normal-looking ileocecal valve does not exclude Crohn's disease in the terminal ileum
28. P020 - RDW — a new diagnostic and activity marker for inflammatory bowel disease
29. P233 CLINICAL FEATURES AND PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE-ASSOCIATED INTESTINAL CANCER
30. P185 MEDIUM-TERM EFFICACY OF INFLIXIMAB INDUCTION THERAPY WITHOUT RETREATMENT IN PATIENTS WITH CROHN'S DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.